A detailed history of Wealth Effects LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wealth Effects LLC holds 14,500 shares of TGTX stock, worth $428,330. This represents 0.13% of its overall portfolio holdings.

Number of Shares
14,500
Previous 16,500 12.12%
Holding current value
$428,330
Previous $293,000 15.7%
% of portfolio
0.13%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$17.21 - $25.28 $34,420 - $50,560
-2,000 Reduced 12.12%
14,500 $339,000
Q1 2024

Apr 22, 2024

BUY
$13.02 - $21.3 $32,550 - $53,250
2,500 Added 17.86%
16,500 $250,000
Q4 2023

Jan 29, 2024

SELL
$6.68 - $18.81 $10,020 - $28,214
-1,500 Reduced 9.68%
14,000 $239,000
Q3 2023

Oct 16, 2023

BUY
$8.36 - $26.5 $129,579 - $410,750
15,500 New
15,500 $129,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.